Molecular mutations as a possible factor for determining extent of thyroid surgery

被引:43
作者
Krasner, Joshua R. [1 ]
Alyouha, Nourah [2 ]
Pusztaszeri, Marc [3 ]
Forest, Veronique-Isabelle [2 ]
Hier, Michael P. [2 ]
Avior, Galit [4 ]
Payne, Richard J. [2 ]
机构
[1] McGill Univ, Fac Sci, 853 Sherbrooke St West, Montreal, PQ, Canada
[2] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Otolaryngol Head & Neck Surg, Montreal, PQ, Canada
[3] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Pathol, Montreal, PQ, Canada
[4] Hillel Yaffe Med Ctr, Fac Med, Dept Otolaryngol Head & Neck Surg, Technion, Hadera, Israel
关键词
Thyroid cancer; Molecular testing; Extent of surgery; BRAF V600E; TERT; RAS; BRAF V600E MUTATION; CLINICOPATHOLOGICAL FEATURES; NODULES; CANCER; ASSOCIATION; BRAF(V600E); CARCINOMA;
D O I
10.1186/s40463-019-0372-5
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Molecular testing of thyroid nodules is a diagnostic tool used to better understand the nature of thyroid nodules. The aim of this study is to better comprehend the relationship between specific mutations and aggressive behavior of the tumour as demonstrated on postoperative pathological analysis. Methods A retrospective chart review of 103 cases was performed. Included were patients who had undergone molecular testing using a panel that tests for 9 mutations (ThyGenX (R)) and were found to have malignant tumours. The following gene alterations were found pre-operatively in the nodules: BRAF V600E (n = 32), BRAF K601E (n = 4), NRAS (n = 11), HRAS (n = 4), KRAS (n = 3), RET/PTC1 rearrangement (n = 1), TERT promoter (n = 2), PAX8-PPAR gamma rearrangement (n = 1), and 45 cases where no mutation was detected. Aggressive behavior was defined by extra-thyroidal extension (ETE), lymph node metastasis (LN+), and the following variants of papillary thyroid carcinoma: tall cell, solid, diffuse sclerosing, columnar cell and hobnail. Chi-squared testing was performed to compare groups. Results The group with BRAF V600E, RET/PTC1 rearrangement, and TERT promoter mutations was associated with ETE 37.1%, and LN+ 45.7% of the time compared to 4.3 and 13.0% in the group with other mutations, and 4.4 and 4.4% in the group with no mutations (p-value 0.02, p-value < 0.001, p-value 0.006). In addition, the BRAF V600E, RET/PTC1 rearrangement, and TERT mutations group demonstrated tall cell variants (17.1%), columnar cell variants (5.7%), and hobnail variants (3%). The other mutations group demonstrated columnar cell variants (4.3%), and the no mutations group demonstrated solid variants (2.2%). Conclusions In this study, BRAF V600E, RET/PTC1 rearrangement, and TERT mutations were associated with aggressive behaving thyroid malignancies as defined above. Molecular testing may be a useful method to anticipate aggressive tumour types and therefore assist in planning the extent and timing of surgery.
引用
收藏
页数:7
相关论文
共 25 条
[1]   Integrated Genomic Characterization of Papillary Thyroid Carcinoma [J].
Agrawal, Nishant ;
Akbani, Rehan ;
Aksoy, B. Arman ;
Ally, Adrian ;
Arachchi, Harindra ;
Asa, Sylvia L. ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Baylin, Stephen B. ;
Behera, Madhusmita ;
Bernard, Brady ;
Beroukhim, Rameen ;
Bishop, Justin A. ;
Black, Aaron D. ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
Bowen, Jay ;
Bowlby, Reanne ;
Bristow, Christopher A. ;
Brookens, Robin ;
Brooks, Denise ;
Bryant, Robert ;
Buda, Elizabeth ;
Butterfield, Yaron S. N. ;
Carling, Tobias ;
Carlsen, Rebecca ;
Carter, Scott L. ;
Carty, Sally E. ;
Chan, Timothy A. ;
Chen, Amy Y. ;
Cherniack, Andrew D. ;
Cheung, Dorothy ;
Chin, Lynda ;
Cho, Juok ;
Chu, Andy ;
Chuah, Eric ;
Cibulskis, Kristian ;
Ciriello, Giovanni ;
Clarke, Amanda ;
Clayman, Gary L. ;
Cope, Leslie ;
Copland, John A. ;
Covington, Kyle ;
Danilova, Ludmila ;
Davidsen, Tanja ;
Demchok, John A. ;
DiCara, Daniel ;
Dhalla, Noreen .
CELL, 2014, 159 (03) :676-690
[2]   The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis [J].
Barbaro, Daniele ;
Incensati, Roberto Mario ;
Materazzi, Gabriele ;
Boni, Giuseppe ;
Grosso, Mariano ;
Panicucci, Erica ;
Lapi, Paola ;
Pasquini, Cristina ;
Miccoli, Paolo .
ENDOCRINE, 2014, 45 (03) :462-468
[3]   Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction [J].
Biron, Vincent L. ;
Matkin, Ashlee ;
Kostiuk, Morris ;
Williams, Jordana ;
Cote, David W. ;
Harris, Jeffrey ;
Seikaly, Hadi ;
O'Connell, Daniel A. .
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 47
[4]   BRAFV600E Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis [J].
Chen, Yufei ;
Sadow, Peter M. ;
Suh, Hyunsuk ;
Lee, Kyu Eun ;
Choi, June Young ;
Suh, Yong Joon ;
Wang, Tracy S. ;
Lubitz, Carrie C. .
THYROID, 2016, 26 (02) :248-255
[5]   A High-Throughput Proteomic Approach Provides Distinct Signatures for Thyroid Cancer Behavior [J].
Cheng, Sonia ;
Serra, Stefano ;
Mercado, Moises ;
Ezzat, Shereen ;
Asa, Sylvia L. .
CLINICAL CANCER RESEARCH, 2011, 17 (08) :2385-2394
[6]  
Dobrinja C, 2010, ANN ITAL CHIR, V81, P403
[7]   The BRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study [J].
Elisei, Rossella ;
Viola, David ;
Torregrossa, Liborio ;
Giannini, Riccardo ;
Romei, Cristina ;
Ugolini, Clara ;
Molinaro, Eleonora ;
Agate, Laura ;
Biagini, Agnese ;
Lupi, Cristiana ;
Valerio, Laura ;
Materazzi, Gabriele ;
Miccoli, Paolo ;
Piaggi, Paolo ;
Pinchera, Aldo ;
Vitti, Paolo ;
Basolo, Fulvio .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12) :4390-4398
[8]   The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases [J].
Eloy, Catarina ;
Santos, Joana ;
Soares, Paula ;
Sobrinho-Simoes, Manuel .
VIRCHOWS ARCHIV, 2011, 459 (03) :265-276
[9]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133
[10]   A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma [J].
Huy Gia Vuong ;
Duong, Uyen N. P. ;
Altibi, Ahmed M. A. ;
Ngo, Hanh T. T. ;
Thong Quang Pham ;
Hung Minh Tran ;
Gandolfi, Greta ;
Hassell, Lewis .
ENDOCRINE CONNECTIONS, 2017, 6 (03) :8-17